Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

CV Therapeutics Raising $288M Via Stock, Notes

June 30, 2005

By Jennifer Boggs

Cougar Adds Seocalcitol, Fattens Oncology Pipeline

June 29, 2005

By Jennifer Boggs

Cougar Adds Seocalcitol, Fattens Oncology Pipeline

June 29, 2005

By Jennifer Boggs

Metabasis Signs AMPK Deal With Merck Worth Up To $74M

June 28, 2005

By Jennifer Boggs

Metabasis Signs AMPK Deal With Merck Worth Up To $74M

June 28, 2005

By Jennifer Boggs

Salix Plans To Acquire InKine In Stock Deal Valued at $190M

June 27, 2005

By Jennifer Boggs

Salix Plans To Acquire InKine In Stock Deal Valued at $190M

June 27, 2005

By Jennifer Boggs

Amoxicillin Pulsys Misses In Phase III Trial; Advancis Falls

June 17, 2005

By Jennifer Boggs

Immtech's SPA Set For Pivotal Trial Of Anti-Infective Product

June 17, 2005

By Jennifer Boggs

Immtech's SPA Set For Pivotal Trial Of Anti-Infective Product

June 17, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 3, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 3, 2025
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...
GLP-1 receptor agonists continue their global victory tour
BioWorld
2024 was another banner year for GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their...
AI drives financings, approvals for APAC med-tech in 2024
BioWorld MedTech
AI pulled in major financings and approvals for Asia med-techs in 2024 as Asia Pacific countries played to individual strengths to maximize AI’s applications in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.